Afficher la notice abrégée

dc.creatorKarangelis, D.en
dc.creatorAsimakopoulou, A.en
dc.creatorKanakis, I.en
dc.creatorTagarakis, G. I.en
dc.creatorKoufakis, T.en
dc.creatorTriposkiadis, F.en
dc.creatorTsilimingas, N.en
dc.creatorKaramanos, N. K.en
dc.date.accessioned2015-11-23T10:33:17Z
dc.date.available2015-11-23T10:33:17Z
dc.date.issued2011
dc.identifier10.1002/bmc.1533
dc.identifier.issn0269-3879
dc.identifier.urihttp://hdl.handle.net/11615/29034
dc.description.abstractGlycosaminoglycans (GAGs) are functionally important molecules of the arterial wall and play a crucial role in atherogenesis. Chondroitin sulfate/dermatan sulfate proteoglycans (CS/DSPGs) participate in several biological events through their GAG chains, and are also involved in the development of atherosclerosis. The aim of this study was to compare the pre- and post-operative levels of CS in serum of patients after coronary artery bypass graft surgery using a highly sensitive reversed-polarity capillary electrophoresis method and to investigate the correlation of CS with common biochemical lipid markers. It was found that CS values were significantly higher for all patients post-operatively and, furthermore, CS levels were statistically correlated to apolipoprotein A and B levels. Notably, the pre-operational lipid profile of the patient may be indicative of the values of 4-sulfated CS post-operationally. Furthermore, the obtained results highlight the clinical significance of CS levels in serum, since they may provide complementary information for the latent inflammatory state of the patient. Copyright (C) 2010 John Wiley & Sons, Ltd.en
dc.sourceBiomedical Chromatographyen
dc.source.uri<Go to ISI>://WOS:000291450300002
dc.subjectproteoglycansen
dc.subjectchondroitin sulfateen
dc.subjectcardiopulmonary bypassen
dc.subjectatherosclerosisen
dc.subjectSMOOTH-MUSCLE CELLSen
dc.subjectCAPILLARY-ELECTROPHORESISen
dc.subjectPROTEOGLYCANSen
dc.subjectGLYCOSAMINOGLYCANSen
dc.subjectDISACCHARIDESen
dc.subjectVERSICANen
dc.subjectLESIONSen
dc.subjectAORTAen
dc.subjectBiochemical Research Methodsen
dc.subjectBiochemistry & Molecular Biologyen
dc.subjectChemistry, Analyticalen
dc.subjectPharmacology & Pharmacyen
dc.titleMonitoring serum chondroitin sulfate levels in patients submitted to coronary artery bypass surgeryen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée